CD4+ T cells identified as key to hepatitis B clearance

Drug Target Review·May 14

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers have identified cd4+ t cells as key to clearing hepatitis b. The liver's immune cells, including t cells, may play a crucial role in finding a cure for the disease. Studies are exploring various strategies, including combination therapies and understanding t cell exhaustion, to overcome hepatitis b.

Full coverage

PD-1/PD-L1 blockade as part of combination strategies toward functional cure of chronic hepatitis B

Frontiers·Jun 24

The liver's immune cells might be the key to curing hepatitis B

Medical Xpress·May 14

Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion

Nature·Jan 1

Identification of key biomarkers associated with necroptosis and immune infiltration in hepatitis B virus-related acute-on-chronic liver failure

Nature·Oct 27

From exhaustion to functional cure: frontiers in reversing HBV-specific T-cell immunity

Frontiers·Jun 10

Hepatitis B virus surface antigen drives T cell immunity through non-canonical antigen presentation in mice

Nature·May 17

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation

Frontiers·Feb 8

T cell dysfunction induced by hepatocellular priming

Nature·Jun 30

View original report at Drug Target Review ↗

Fetching the latest headlines…